Anti-hepatitis B core positivity as a risk factor for hepatocellular carcinoma in alcoholic cirrhosis: A case-control study

Alcohol

Volumn 46, Issue 6, 2012, Pages 537-541

  Kwon, Oh Sang ^a   Jung, Young Kul ^a   Bae, Kyoung Suk ^a   Kim, Ju Hyun ^a   Kim, Sang Gyune ^b   Kim, Young Seok ^b   Lee, Jung Il ^c   Lee, Jin Woo ^c   Kim, Yun Soo ^a  

^a Gachon University   (South Korea)

^b Soonchunhyang University College of Medicine   (South Korea)

^c Inha University Hospital   (South Korea)

Author keywords

Alcoholic cirrhosis; Case control study; Hepatitis B core; Hepatocellular carcinoma; Risk factor

Indexed keywords

HEPATITIS B CORE ANTIBODY; VIRUS DNA;

ADULT; ALCOHOL CONSUMPTION; ALCOHOL LIVER CIRRHOSIS; ARTICLE; CANCER INCIDENCE; CASE CONTROL STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; HEPATITIS B; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RISK FACTOR; SCORING SYSTEM; SOUTH KOREA;

AGED; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HUMANS; LIVER CIRRHOSIS, ALCOHOLIC; LIVER NEOPLASMS; MALE; MIDDLE AGED; RISK FACTORS;

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

EID: 84864526818     PISSN: 07418329     EISSN: 18736823     Source Type: Journal    
DOI: 10.1016/j.alcohol.2012.03.006     Document Type: Article

References (30)

1. Adachi H., Kaneko S., Matsushita E., Inagaki Y., Unoura M., Kobayashi K. Clearance of HBsAg in seven patients with chronic hepatitis B. Hepatology 1992, 16:1334-1337.
2. Ahn S.H., Park Y.N., Park J.Y., Chang H.Y., Lee J.M., Shin J.E., et al. Long-term clinical and histological outcomes in patients with spontaneous hepatitis B surface antigen seroclearance. Journal of Hepatology 2005, 42:188-194.
3. Bréchot C., Thiers V., Kremsdorf D., Nalpas B., Pol S., Paterlini-Bréchot P. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely " occult" Hepatology 2001, 34:194-203.
4. Cabrerizo M., Bartolomé J., Caramelo C., Barril G., Carreno V. Molecular analysis of hepatitis B virus DNA in serum and peripheral blood mononuclear cells from hepatitis B surface antigen-negative cases. Hepatology 2000, 32:116-123.
5. Chung H.T., Lai C.L., Lok A.S. Pathogenic role of hepatitis B virus in hepatitis B surface antigen-negative decompensated cirrhosis. Hepatology 1995, 22:25-29.
6. Coffin C.S., Michalak T.I. Persistence of infectious hepadnavirus in the offspring of woodchuck mothers recovered from viral hepatitis. Journal of Clinical Investigation 1999, 104:203-212.
7. Conjeevaram H.S., Lok A.S. Occult hepatitis B virus infection: a hidden menace?. Hepatology 2001, 34:204-206.
8. Corrao G., Aricò S. Independent and combined action of hepatitis C virus infection and alcohol consumption on the risk of symptomatic liver cirrhosis. Hepatology 1998, 27:914-919.
9. Donato F., Tagger A., Gelatti U., Parrinello G., Boffetta P., Albertini A., et al. Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women. American Journal of Epidemiology 2002, 155:323-331.
10. El-Serag H.B., Rudolph K.L., Michael E. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007, 132:2557-2576.
11. Fattovich G., Stroffolini T., Zagni I., Donato F. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 2004, 127:35S-50S.
12. Hassan M.M., Hwang L.Y., Hatten C.J., Swaim M., Li D., Abbruzzese J.L., et al. Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology 2002, 36:1206-1213.
13. Huo T.I., Wu J.C., Lee P.C., Chau G.Y., Lui W.Y., Tsay S.H., et al. Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis. Hepatology 1998, 28:231-236.
14. Jilg W., Sieger E., Zachoval R., Schätzl H. Individuals with antibodies against hepatitis B core antigen as the only serological marker for hepatitis B infection: high percentage of carriers of hepatitis B and C virus. Journal of Hepatology 1995, 23:14-20.
15. Korean Liver Cancer Study Group, National Cancer Center Practice guidelines for management of hepatocellular carcinoma 2009. Korean Journal of Hepatology 2009, 15:391-423.
16. Lee C.H. Alcoholic liver disease. Gastrointestinal diseases 2000, 578-583. Ilchokak, Seoul. J.R. Kim (Ed.).
17. Lok A.S., Liang R.H., Chiu E.K., Wong K.L., Chan T.K., Todd D. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study. Gastroenterology 1991, 100:182-188.
18. Midanik L. The validity of self-reported alcohol consumption and alcohol problems: a literature review. British Journal of Addiction 1982, 77:357-382.
19. Nirei K., Kaneko M., Moriyama M., Arakawa Y. The clinical features of chronic hepatitis C are not affected by the coexistence of hepatitis B virus DNA in patients negative for hepatitis B surface antigen. Intervirology 2000, 43:95-101.
20. Paterlini P., Poussin K., Kew M., Franco D., Brechot C. Selective accumulation of the X transcript of hepatitis B virus in patients negative for hepatitis B surface antigen with hepatocellular carcinoma. Hepatology 1995, 21:313-321.
21. Perrillo R.P. Acute flares in chronic hepatitis B: the natural and unnatural history of an immunologically mediated liver disease. Gastroenterology 2001, 120:1009-1022.
22. Pontisso P., Morsica G., Ruvoletto M.G., Barzon M., Perilongo G., Basso G., et al. Latent hepatitis B virus infection in childhood hepatocellular carcinoma. Analysis by polymerase chain reaction. Cancer 1992, 69:2731-2735.
23. Raimondo G., Allain J.P., Brunetto M.R., Buendia M.A., Chen D.S., Colombo M., et al. Statements from the Taormina expert meeting on occult hepatitis B virus infection. Journal of Hepatology 2008, 49:652-657.
24. Raimondo G., Pollicino T., Romanò L., Zanetti A.R. A 2010 update on occult hepatitis B infection. Pathologie Biologie (Paris) 2010, 58:254-257.
25. Shibata Y., Nakata K., Tsuruta S., Hamasaki K., Hayashida Y., Kato Y., et al. Detection of hepatitis B virus X-region DNA in liver tissue from patients with hepatitis C virus-associated cirrhosis who subsequently developed hepatocellular carcinoma. International Journal of Oncology 1999, 14:1153-1156.
26. Shiota G., Oyama K., Udagawa A., Tanaka K., Nomi T., Kitamura A., et al. Occult hepatitis B virus infection in HBs antigen-negative hepatocellular carcinoma in a Japanese population: involvement of HBx and p53. Journal of Medical Virology 2000, 62:151-158.
27. Stickel F., Schuppan D., Hahn E.G., Seitz H.K. Cocarcinogenic effects of alcohol in hepatocarcinogenesis. Gut 2002, 51:132-139.
28. Voigt M.D. Alcohol in hepatocellular cancer. Clinics in Liver Disease 2005, 9:151-169.
29. Yotsuyanagi H., Shintani Y., Moriya K., Fujie H., Tsutsumi T., Kato T., et al. Virologic analysis of non-B, non-C hepatocellular carcinoma in Japan: frequent involvement of hepatitis B virus. Journal of Infectious Diseases 2000, 181:1920-1928.
30. Yu M.C., Yuan J.M., Ross R.K., Govindarajan S. Presence of antibodies to the hepatitis B surface antigen is associated with an excess risk for hepatocellular carcinoma among non-Asians in Los Angeles County, California. Hepatology 1997, 25:226-228.